| 1JV8 | A:4-56 | NMR STRUCTURE OF BPTI MUTANT G37A |
| 1K09 | B:2-25; B:2-25 | SOLUTION STRUCTURE OF BETACORE, A DESIGNED WATER SOLUBLE FOUR-STRANDED ANTIPARALLEL B-SHEET PROTEIN |
| 1LD5 | A:4-56 | STRUCTURE OF BPTI MUTANT A16V |
| 1MTN | H:304-356; H:304-356 | BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION |
| 1OA5 | 5:4-56 | THE SOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR AT HIGH PRESSURE |
| 1OA6 | 5:4-56 | THE SOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR AT HIGH PRESSURE |
| 1P2I | I:4-56 | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN |
| 1P2J | I:4-56 | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN |
| 1P2K | I:4-56 | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN |
| 1P2M | D:4-56; D:4-56 | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN |
| 1P2N | D:4-56; D:4-56 | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN |
| 1P2O | D:4-56; D:4-56 | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN |
| 1P2Q | D:4-56; D:4-56 | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN |
| 1QLQ | A:4-56 | BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH ALTERED BINDING LOOP SEQUENCE |
| 1T8L | D:4-56; D:4-56 | CRYSTAL STRUCTURE OF THE P1 MET BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
| 1T8N | D:4-56; D:4-56 | CRYSTAL STRUCTURE OF THE P1 THR BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
| 1T8O | D:4-56; D:4-56 | CRYSTAL STRUCTURE OF THE P1 TRP BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
| 1TPA | I:4-56 | THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS |
| 1UUA | A:2-54 | SOLUTION STRUCTURE OF A TRUNCATED BOVINE PANCREATIC TRYPSIN INHIBITOR, 3-58 BPTI |
| 1UUB | A:2-54 | SOLUTION STRUCTURE OF A TRUNCATED BOVINE PANCREATIC TRYPSIN INHIBITOR MUTANT, 3-58 BPTI (K15R, R17A, R42S) |
| 1YKT | B:4-56 | TRYPSIN/BPTI COMPLEX MUTANT |
| 2KAI | I:4-56 | REFINED 2.5 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BY PORCINE KALLIKREIN A AND THE BOVINE PANCREATIC TRYPSIN INHIBITOR. CRYSTALLIZATION, PATTERSON SEARCH, STRUCTURE DETERMINATION, REFINEMENT, STRUCTURE AND COMPARISON WITH ITS COMPONENTS AND WITH THE BOVINE TRYPSIN-PANCREATIC TRYPSIN INHIBITOR COMPLEX |
| 2PTC | I:4-56 | THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS |
| 2R9P | I:4-56; I:4-56; I:4-56; I:4-56 | HUMAN MESOTRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR(BPTI) |
| 2RA3 | I:4-56; I:4-56 | HUMAN CATIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) |
| 2TPI | I:4-56 | ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY |
| 2ZJX | B:4-56; B:4-56 | BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) CONTAINING ONLY THE [5,55] DISULFIDE BOND |
| 2ZVX | B:4-56; B:4-56 | STRUCTURE OF A BPTI-[5,55] VARIANT CONTAINING GLY/VAL AT THE 14/38TH POSITIONS |
| 3LDJ | C:4-56; C:4-56; C:4-56 | CRYSTAL STRUCTURE OF APROTININ IN COMPLEX WITH SUCROSE OCTASULFATE: UNUSUAL INTERACTIONS AND IMPLICATION FOR HEPARIN BINDING |
| 3OTJ | I:4-56 | A CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BPTI (BOVINE PANCREATIC TRYPSIN INHIBITOR) BY X-RAY/NEUTRON JOINT REFINEMENT |
| 3TGI | I:4-56 | WILD-TYPE RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) |
| 3TGJ | I:4-56 | S195A TRYPSINOGEN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) |
| 3TPI | I:4-56 | THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS |
)
)